Treatment of Obesity Nutritional, Metabolic, Endocrine Obesity
Conditions
Interventions
This AspireAssist Aspiration Therapy study is an interventional study without a control. The intervention requires percutaneous endoscopic replacement of the 6mm A-Tube which is similar to a standard
Sponsors
Aspire Bariatrics, Inc. (USA)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient should currently be a user of the AspireAssist device and have used it for at least six (6) months
Exclusion criteria
Exclusion criteria: 1. Active infection at the A-Tube 2. Recent (1 month) myocardial infarction 3. The patient is for some reason not considered likely to follow the instructions in the study with respect to diary completion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The dependent variable: aspiration time, number of blockages of food at the start of the study and at 7 weeks 2. Independent variables: 6mm A-Tube or 8mm A-Tube, chewing time | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The dependent variable: complications (yes/no) 2. Independent variables: 6mm A-Tube or 8mm A-Tube | — |
Countries
Sweden
Outcome results
None listed